Home - Clinical Trials Arena
WEBKezar Life Sciences suspends subject enrolment in trial of lupus nephritis drug. According to the safety findings, four Grade Five serious adverse events were reported during the Phase II PALIZADE trial. News.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
News - Clinical Trials Arena
WEBBiomea’s stock bounces back as FDA lifts clinical hold on diabetes trials. Biomea Fusion’s stock is on the up after the company plans to resume two clinical trials evaluating its type 1…. Phalguni Deswal. News.
Novo Nordisk launches trial of pipeline drug CagriSema versus …
WEBNov 17, 2023 · Novo Nordisk launches trial of pipeline drug CagriSema versus newly approved Zepbound. The launch of this Phase III comparative trial by Novo Nordisk might imply that CagriSema and Zepbound are expected to become direct competitors once Novo Nordisk’s candidate reaches the market.
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
WEBFeb 2, 2023 · Pfizer and Moderna eye seasonal influenza. The two largest mRNA vaccine trials with readouts in 2023 are for seasonal influenza. First up, Moderna’s 6,102-patient, Phase III trial of mRNA-1010 (NCT05415462) has immunogenicity data expected in Q1 2023. The trial is testing mRNA-1010 against an active comparator vaccine, with primary …
Hepatitis B: Four trials to watch over the next 12 months
WEBJul 28, 2023 · Hepatitis B immune globulin (Hepatect, Nabi-HB, Zutectra, Neohepatect, Fovepta) contains mainly immunoglobulin G and acts as passive immunising preparation. The two cohorts are HBsAg positive and HBeAg negative, with one group having had no treatment while the other group will have been treated with anti-HBV NUC for at least 12 …
Jemperli (dostarlimab-gxly) to Treat Advanced Solid Tumours
WEBSep 29, 2023 · Jemperli (dostarlimab-gxly) is an anti-programmed cell death receptor-1 (PD-1) antibody indicated for the treatment of adults with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours and dMMR-recurrent or advanced endometrial cancer. Dostarlimab was discovered by AnaptysBio, a biotechnology company based in the US, …
Ozempic (semaglutide) for the Treatment of Type 2 Diabetes
WEBOzempic ® (semaglutide) is a glucagon-like peptide (GLP-1) receptor agonist indicated for the treatment of Type 2 diabetes in adults. The drug was discovered and developed by Novo Nordisk, which submitted a new drug application (NDA) for the drug to the US Food and Drug Administration (FDA) under the Prescription Drug User Fee Act V (PDUFA V ...
Nothing to sneeze at: nasal sprays to tackle Covid-19
WEBJul 27, 2021 · Since the outbreak of Covid-19 worldwide, scientists and pharmaceutical companies alike have raced to find ways to protect against and treat the virus.One method of administration increasingly being pursued is the nasal spray; the cells lining the nose have been identified as a key entry point for the novel coronavirus, and a spray …
- Some results have been removed